IUS2:F:F-iShares S&P U.S. Banks UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 5.169

Change

+0.04 (+0.78)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-28 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.11 (-0.41%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.27 (-0.54%)

USD 108.20B
SXR8:F iShares Core S&P 500 UCITS ETF..

+1.02 (+0.19%)

USD 93.32B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

-0.29 (-0.52%)

USD 86.92B
SXRZ:F iShares VII PLC - iShares Nikk..

-1.50 (-0.64%)

USD 53.24B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.48 (+0.50%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.12 (-0.77%)

USD 51.19B
XJSE:F Xtrackers II - Japan Governmen..

+0.08 (+0.96%)

USD 41.09B
0ZC:F Zscaler Inc

+5.84 (+4.01%)

USD 37.92B

ETFs Containing IUS2:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.49% 80% B- 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.49% 77% C+ 64% D
Trailing 12 Months  
Capital Gain 39.59% 93% A 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 39.59% 91% A- 77% C+
Trailing 5 Years  
Capital Gain 32.01% 54% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 32.01% 54% F 47% F
Average Annual (5 Year Horizon)  
Capital Gain 10.95% 79% B- 73% C
Dividend Return 10.95% 76% C+ 66% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 37.61% 7% C- 30% F
Risk Adjusted Return 29.12% 48% F 56% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.